No takes yet. Share an insight, caveat, or question.
Multicenter study evaluates progression-free survival in relapsed large B cell lymphoma with bispecific antibodies and CAR T cell therapy, indicating treatment sequencing impacts efficacy.
Qualls et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: